Skip to main content

Talos

Agency execution software for institutions

Institutional Execution Platforms
#4 Overall

Ranked #4 of 6 institutional execution platforms in the published ranking

63 out of 100
ChainChoice ScoreThe ChainChoice Score, shown against 100: published scores run from 41 to 99.
  • High evidence confidence

Is Talos right for you?

Right for you if these matter most

  • You say you connect to 100+ venues — can I check that anywhere you don't control?8/10, the category best
  • Who am I contracting with, who pays you — and will anyone name a price before the sales call?7/10; the category best is 8

Look elsewhere if these come first

  • Can I actually read your documentation before I sign your NDA?4/10 here; sFOX (EMS/agency execution surface only) scores 9
  • When your system goes down, will I find out from you — or from my own blotter?1/10 here; CoinRoutes scores 9

Not yet tested for your country. Markets it lists: Global.

to test where you can use it.

The rank above is the published one, the same for every reader. Find my best institutional execution platform shows where it lands for you.

What will Talos cost you?

Not priced on this basis

Your monthly volume
$1k
How this is calculated

How safe is Talos?

  • Evidence: verified4 of 4 criteria rest on quoted, sourced receipts. Read September 2026.
  • LicenceMiCA (EU): no register record on file here.
Open the evidence

Alternatives to Talos

Compare all 4
  1. 2CoinRoutes2 points above · stronger on operational transparency and incident history (9 against 1)65 out of 100
  2. 3sFOX (EMS/agency execution surface only)1 point above · stronger on pre nda documentation surface (9 against 4)64 out of 100
  3. 5Wyden (ex-AlgoTrader)9 points below · stronger on operational transparency and incident history (2 against 1)54 out of 100
View all 6 ranked institutional execution platforms

Provider at a glance

Category
Institutional Execution Platforms
Entity
Not verified
Official website
talos.com

Independent rankingchecked How it works

Details

Scored 63 out of 100 under methodology 2026.10.18, from the evidence read in September 2026.